Drug Sponsors

SRI International to develop bioadhesive gel for HIV and HSV

Monday, July 30, 2012 10:09 AM

SRI International, a global nonprofit research institute, has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) that will support the development of a topical microbicide gel for combination therapy against human immunodeficiency virus (HIV) and herpes simplex virus type 2 (HSV-2) infections in women.

More... »

Proteostasis, Scripps Research expand collaboration on cystic fibrosis

Friday, July 27, 2012 12:04 PM

Proteostasis Therapeutics, a therapeutics developer focusing on regulating protein homeostasis for neurodegenerative and orphan diseases, has expanded its collaboration with The Scripps Research Institute (TSRI) to encompass an additional funded research project focused on biology and the testing of small molecule modulators of protein folding and trafficking for the treatment of cystic fibrosis (CF).

More... »

Gentris collaborates on blood stability

Thursday, July 26, 2012 03:29 PM

Gentris, a provider of pharmacogenomics and biorepository solutions, will begin a collaborative study with a major pharmaceutical company to test the long-term stability of DNA in whole blood samples that have been stored for five and 10 years.

More... »

GE Healthcare and iBio form new global alliance

Thursday, July 26, 2012 02:34 PM

GE Healthcare and iBio, a Newark, Del.-based provider of pharmaceutical product applications, have formed a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

More... »

Biodel awarded NIH grant to develop ultra-rapid-acting insulin for artificial pancreas

Thursday, July 26, 2012 10:42 AM

The Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel, a Danbury, Conn.-based specialty biopharmaceutical company, a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.

More... »

Genentech and Novartis rank as image leaders among oncologists, hematologists

Wednesday, July 25, 2012 09:59 AM

Genentech and Novartis have the best image among oncologists and hematologists, according to Market Strategies International, a market research consultancy that recently completed its 2012 Oncology Image Study.

More... »

Boehringer Ingelheim acquires Funxional's FX125L and somatotaxin portfolio

Monday, July 23, 2012 03:49 PM

Boehringer Ingelheim has agreed to acquire global rights to Funxional Therapeutics’ FX125L compound and somatotaxin program.

More... »

Cell Medica secures $26.5M to establish U.S. operations and fund cell therapy development

Monday, July 23, 2012 03:04 PM

Cell Medica, a London-based cell therapeutics company, has secured a $26.5 million equity investment to launch new operations in Texas focusing on cancer immunotherapy and to continue development of its immune reconstitution cell therapies in Europe.

More... »

PTC Therapeutics raises $30M for ataluren in muscular dystrophy

Monday, July 23, 2012 12:36 PM

PTC Therapeutics, a biopharmaceutical company based in South Plainfield, N.J., has completed a $30 million round of financing. The round included a number of long-term investors such as Credit Suisse First Boston Equity Partners, HBM BioVentures, Vulcan Ventures, Celgene, Delphi Ventures, The Column Group, Novo A/S and other existing investors.

More... »

Novavax, PATH to produce vaccines for low-income countries

Monday, July 23, 2012 11:26 AM

Novavax, a clinical-stage biopharmaceutical company based in Rockville, Md., has partnered with international non-profit organization PATH to develop a vaccine against respiratory syncytial virus (RSV) — the most common cause of childhood respiratory infection globally — for infants in low-income countries with a high disease burden.

More... »